Vinigrol, a novel antihypertensive and platelet aggregation inhibitory agent produced by a fungus, Virgaria nigra. II. Pharmacological characteristics

J Antibiot (Tokyo). 1988 Jan;41(1):31-5. doi: 10.7164/antibiotics.41.31.

Abstract

Vinigrol, a novel diterpene produced by Virgaria nigra, was tested orally in conscious spontaneously hypertensive rats (SHR) to confirm its antihypertensive activity. Vinigrol (2 mg/kg, po) decreased the mean arterial blood pressure of SHR by approximately 15% for at least 6 hours. Vinigrol induced contraction of rat aortic smooth muscle preparation at 1.5 X 10(-7) M, the contraction was blocked by nilvadipine, a Ca2+ entry blocker, but was not inhibited by prazosin or yohimbine. Radio-receptor binding assay of alpha adrenoceptors of rat brain membrane revealed that vinigrol had no affinity for these receptors.

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology*
  • Blood Pressure / drug effects
  • Calcium / metabolism
  • Diterpenes / pharmacology*
  • In Vitro Techniques
  • Male
  • Mitosporic Fungi / analysis
  • Platelet Aggregation Inhibitors / pharmacology*
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred Strains
  • Receptors, Adrenergic, alpha / drug effects
  • Vasoconstriction / drug effects

Substances

  • Antihypertensive Agents
  • Diterpenes
  • Platelet Aggregation Inhibitors
  • Receptors, Adrenergic, alpha
  • vinigrol
  • Calcium